Baxter International (Vero cell technology) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Baxter International (Vero cell technology) General Information

Description

Producer and provider of vaccines. The unit is an advanced, cell-based technology for vaccines production. It is used to produce vaccines including H5N1, H1N1 and seasonal influenza. It includes Baxter's production facility in Bohumil, Czech Republic.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Corporate Office
  • Bohumil
  • Czech Republic

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Baxter International (Vero cell technology) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Baxter International (Vero cell technology)‘s full profile, request access.

Request a free trial

Baxter International (Vero cell technology) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Baxter International (Vero cell technology)‘s full profile, request access.

Request a free trial

Baxter International (Vero cell technology) FAQs

  • Where is Baxter International (Vero cell technology) headquartered?

    Baxter International (Vero cell technology) is headquartered in Bohumil, Czech Republic.

  • What industry is Baxter International (Vero cell technology) in?

    Baxter International (Vero cell technology)’s primary industry is Drug Delivery.

  • Is Baxter International (Vero cell technology) a private or public company?

    Baxter International (Vero cell technology) is a Private company.

  • What is Baxter International (Vero cell technology)’s current revenue?

    The current revenue for Baxter International (Vero cell technology) is 000000.

  • Who are Baxter International (Vero cell technology)’s investors?

    Baxter International has invested in Baxter International (Vero cell technology).

  • When was Baxter International (Vero cell technology) acquired?

    Baxter International (Vero cell technology) was acquired on 01-Dec-2014.

  • Who acquired Baxter International (Vero cell technology)?

    Baxter International (Vero cell technology) was acquired by Ology Bioservices.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »